These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 19741461)

  • 1. Mammalian target of rapamycin inhibition prevents glomerular hypertrophy in a model of renal mass reduction.
    Rovira J; Arellano EM; Carreras J; Campos B; Vodenik B; Bañón-Maneus E; Ramírez-Bajo MJ; Moya-Rull D; Solé-González A; Hernández A; Revuelta I; Quintana LF; Howat WJ; Campistol JM; Diekmann F
    Transplantation; 2009 Sep; 88(5):646-52. PubMed ID: 19741461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mTOR inhibitor everolimus induces proteinuria and renal deterioration in the remnant kidney model in the rat.
    Vogelbacher R; Wittmann S; Braun A; Daniel C; Hugo C
    Transplantation; 2007 Dec; 84(11):1492-9. PubMed ID: 18091526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammalian target of rapamycin pathway blockade slows progression of diabetic kidney disease in rats.
    Lloberas N; Cruzado JM; Franquesa M; Herrero-Fresneda I; Torras J; Alperovich G; Rama I; Vidal A; Grinyó JM
    J Am Soc Nephrol; 2006 May; 17(5):1395-404. PubMed ID: 16597691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteinuria in transplant patients associated with sirolimus.
    Franco AF; Martini D; Abensur H; Noronha IL
    Transplant Proc; 2007 Mar; 39(2):449-52. PubMed ID: 17362756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammalian target of rapamycin inhibition halts the progression of proteinuria in a rat model of reduced renal mass.
    Diekmann F; Rovira J; Carreras J; Arellano EM; Bañón-Maneus E; Ramírez-Bajo MJ; Gutiérrez-Dalmau A; Brunet M; Campistol JM
    J Am Soc Nephrol; 2007 Oct; 18(10):2653-60. PubMed ID: 17804674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different renal toxicity profiles in the association of cyclosporine and tacrolimus with sirolimus in rats.
    Lloberas N; Torras J; Alperovich G; Cruzado JM; Giménez-Bonafé P; Herrero-Fresneda I; Franquesa Ml; Rama I; Grinyó JM
    Nephrol Dial Transplant; 2008 Oct; 23(10):3111-9. PubMed ID: 18469305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapamycin ameliorates proteinuria-associated tubulointerstitial inflammation and fibrosis in experimental membranous nephropathy.
    Bonegio RG; Fuhro R; Wang Z; Valeri CR; Andry C; Salant DJ; Lieberthal W
    J Am Soc Nephrol; 2005 Jul; 16(7):2063-72. PubMed ID: 15917339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of proteinuria predicts improvement in renal function after conversion to sirolimus-based immunosuppressive regimens in lung transplant survivors with chronic kidney disease.
    Stephany BR; Boumitri M; Budev M; Alao B; Poggio ED
    J Heart Lung Transplant; 2009 Jun; 28(6):564-71. PubMed ID: 19481016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulse mTOR inhibitor treatment effectively controls cyst growth but leads to severe parenchymal and glomerular hypertrophy in rat polycystic kidney disease.
    Wu M; Arcaro A; Varga Z; Vogetseder A; Le Hir M; Wüthrich RP; Serra AL
    Am J Physiol Renal Physiol; 2009 Dec; 297(6):F1597-605. PubMed ID: 19776171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with proteinuria in renal transplant recipients treated with sirolimus.
    Liew A; Chiang GS; Vathsala A
    Transpl Int; 2009 Mar; 22(3):313-22. PubMed ID: 19054382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of sirolimus in the development of chronic allograft nephropathy.
    Gürkan A; Kaçar S; Erdoğdu U; Varilsüha C; Kandemir G; Karaca C; Akman F
    Transplant Proc; 2008; 40(1):114-6. PubMed ID: 18261561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapamycin prevents early steps of the development of diabetic nephropathy in rats.
    Yang Y; Wang J; Qin L; Shou Z; Zhao J; Wang H; Chen Y; Chen J
    Am J Nephrol; 2007; 27(5):495-502. PubMed ID: 17671379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mTOR inhibition and erythropoiesis: microcytosis or anaemia?
    Diekmann F; Rovira J; Diaz-Ricart M; Arellano EM; Vodenik B; Jou JM; Vives-Corrons JL; Escolar G; Campistol JM
    Nephrol Dial Transplant; 2012 Feb; 27(2):537-41. PubMed ID: 21785038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A re-evaluation of the renal ablation model of progressive renal disease in rats.
    Kim KH; Kim Y; Park HW; Jeong HJ; Mauer M
    J Nephrol; 2003; 16(2):196-202. PubMed ID: 12768066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renoprotective effects of sirolimus in non-immune initiated focal segmental glomerulosclerosis.
    Rangan GK; Coombes JD
    Nephrol Dial Transplant; 2007 Aug; 22(8):2175-82. PubMed ID: 17550925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapamycin has dual opposing effects on proteinuric experimental nephropathies: is it a matter of podocyte damage?
    Torras J; Herrero-Fresneda I; Gulias O; Flaquer M; Vidal A; Cruzado JM; Lloberas N; Franquesa Ml; Grinyó JM
    Nephrol Dial Transplant; 2009 Dec; 24(12):3632-40. PubMed ID: 19671594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A combination of Chinese herbs, Astragalus membranaceus var. mongholicus and Angelica sinensis, improved renal microvascular insufficiency in 5/6 nephrectomized rats.
    Song J; Meng L; Li S; Qu L; Li X
    Vascul Pharmacol; 2009; 50(5-6):185-93. PubMed ID: 19563735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of rosuvastatin on glomerular capillary size-selectivity function in rats with renal mass ablation.
    Corna D; Sangalli F; Cattaneo D; Carrara F; Gaspari F; Remuzzi A; Zoja C; Benigni A; Perico N; Remuzzi G
    Am J Nephrol; 2007; 27(6):630-8. PubMed ID: 17851231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired glomerular and tubular function as a short-term effect of sirolimus treatment in the rat.
    Nielsen FT; Starklint H; Dieperink H
    Am J Nephrol; 2005; 25(4):411-6. PubMed ID: 16088082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycophenolate mofetil prevents the progressive renal failure induced by 5/6 renal ablation in rats.
    Romero F; Rodríguez-Iturbe B; Parra G; González L; Herrera-Acosta J; Tapia E
    Kidney Int; 1999 Mar; 55(3):945-55. PubMed ID: 10027931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.